Thymogen
Also called Glu-Trp, Thymogen alpha-1
Intranasal (in the nose)Human study reference
Research reference
Human study
Thymogen preoperative study
Daily intranasal study exposure; amount withheld because the indexed abstract's unit needs full-text confirmation
7 days before surgery
Thymogen randomized preoperative study (2011) ↗When results may show
- When change was measured
- A short perioperative immune study is not a general infection-prevention or longevity timeline.
- When to assess
- 7 days before surgery
- Conditions and limitations
- Older adults awaiting abdominal or retroperitoneal tumor surgery. The abstract prints 100 mg; this review does not silently change it to mcg or expose that unresolved amount as a usable protocol.
- When to stop
- The measured study window is not a validated personal quit rule. Do not increase or prolong exposure because an expected result is absent; severe or persistent reactions need prompt clinical review.
Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 0.98× single dose
- Time to steady state
- 1hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Thymogen randomized preoperative study (2011)The abstract prints 100 mg; this review does not silently change it to mcg or expose that unresolved amount as a usable protocol.